Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bilirubin Assay for Neonates Takes Only 60 Seconds

By LabMedica International staff writers
Posted on 14 Mar 2011
A neonatal total bilirubin assay requires only 100 µL of blood and offers test results in about 60 seconds.

The neonatal total bilirubin (nBili) test is performed on the RAPIDPoint 405 blood gas analyzer with software version 3.7. More...
With one small blood sample, a full range of analytes can be measured including bilirubin, blood gases, electrolytes, glucose, total hemoglobin, and other critical care parameters required to assess critically ill infants.

The RAPIDPoint 405 offers a no-maintenance, cartridge-based solution for critical care testing of whole blood--unlike the reagent-based chemistry analyzers that require the separation of plasma from the red blood cells prior to analysis. Ease of use, minimal sample size, and fast turnaround of test results enhance patient care.

Siemens (Erlangen, Germany) nBili test on the RAPIDPoint 405 Blood Gas Analyzer is intended to measure the concentration of bilirubin in an infant's blood as an aid for assessing the risk for kernicterus in a point-of-care setting.

Kernicterus is due to marked jaundice in the newborn period. The high blood level of the pigment bilirubin results in its deposition in the brain, which damages the brain. Today, no baby should develop brain damage from untreated jaundice. If a baby gets too jaundiced, the baby can be treated with phototherapy. The baby can be put under blue lights most of the day. If the baby gets very jaundiced, an exchange transfusion can be done. Kernicterus is also called bilirubin encephalopathy.

Related Links:

Siemens


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.